# Filing Timeline ‚Äî AQUA-V Patent Portfolio

**Portfolio:** AQUA-V (QAPD + QAOS)  
**Reference Date (Day 0):** 2026-02-19  
**Authority:** ASIT / CCB  
**Governance:** EU Framework ‚Äî IP registries reside in the EU (EPO, Munich)

> **EU Framework constraint:** All priority-setting filings are made at the EPO (EU institution). PCT filings designate EPO as ISA. Unitary Patent requested upon EP grant for EU-wide coverage under single EU registry.

---

## Gantt-Style Milestone Table

| Milestone | Target Date | IP Registry | Notes |
|---|---|---|---|
| **PHASE 1 ‚Äî EU Priority Establishment** | | | |
| P0 EP application filed at EPO | 2026-02-26 | **EPO ‚Äî Munich üá©üá™ (EU)** | Sets global EU priority anchor |
| C1.2 EP application filed at EPO | 2026-03-05 | **EPO ‚Äî Munich üá©üá™ (EU)** | Deterministic Pipelines ‚Äî highest priority child |
| C2.1 EP application filed at EPO | 2026-03-05 | **EPO ‚Äî Munich üá©üá™ (EU)** | Resource Orchestrator ‚Äî backed by QAOS.py |
| C1.1 EP application filed at EPO | 2026-03-19 | **EPO ‚Äî Munich üá©üá™ (EU)** | Hybrid QUBO Encoding |
| C2.3 EP application filed at EPO | 2026-03-19 | **EPO ‚Äî Munich üá©üá™ (EU)** | Evidence Ledger |
| **PHASE 1 COMPLETE** | 2026-03-19 | EPO | All EU priority dates set |
| | | | |
| **PHASE 2 ‚Äî PCT Umbrella (EPO as ISA)** | | | |
| PCT application for P0 filed | 2027-02-19 | WIPO Geneva ‚Üí EPO as ISA | Claims priority from P0 EP filing |
| PCT application for C1.2 filed | 2027-02-26 | WIPO ‚Üí EPO as ISA | Combined or separate PCT |
| PCT application for C2.1 filed | 2027-02-26 | WIPO ‚Üí EPO as ISA | Combined or separate PCT |
| International Search Report received (EPO ISA) | 2027-06-19 | EPO | ~4 months post-PCT; high EU quality |
| Written Opinion received | 2027-06-19 | EPO | EU examiner feedback |
| PCT published (18 months from EP priority) | 2027-08-19 | WIPO | Public disclosure |
| International Preliminary Examination Report | 2027-08-19 | EPO | Chapter II if requested |
| **PHASE 2 COMPLETE** | 2027-08-19 | | PCT phase active |
| | | | |
| **PHASE 3 ‚Äî Unitary Patent + Non-EU National Phase** | | | |
| EP grant (P0) target | 2028-06-19 | **EPO** | Subject to prosecution |
| **Unitary Patent request filed** | 2028-07-19 | **EPO ‚Äî EU Unitary Patent Register** | Single EU-wide protection in 18+ states; filed within 1 month of grant |
| EP validation (CH, NO, TR ‚Äî non-UP EPC states) | 2028-07-19 | National IP offices | Switzerland, Norway, Turkey |
| UK national phase filed (UKIPO) | 2028-07-19 | UKIPO (London) | Separate post-Brexit; secondary |
| Non-EU national phase deadline (30 months) | **2028-08-19** | Various | Hard statutory deadline for PCT states |
| US national phase filed (USPTO) | 2028-07-19 | USPTO (secondary) | US market; non-EU registry |
| Canada national phase filed | 2028-08-01 | CIPO (secondary) | |
| Japan national phase filed | 2028-08-01 | JPO (secondary) | Requires JP translation |
| **NATIONAL PHASE ENTRY COMPLETE** | 2028-08-19 | | All jurisdictions filed |
| | | | |
| **PHASE 4 ‚Äî Prosecution** | | | |
| First Office Action (EPO) expected | 2027-08-19 | EPO | ~18 months post EP filing (after ISR) |
| Response to EPO OA deadline | 2027-12-19 | EPO | 4 months from OA (extendable) |
| Oral Proceedings (EPO, if required) | TBD | EPO ‚Äî Munich / The Hague / Berlin | Optional; requested by examiner or applicant |
| First Office Action (USPTO) expected | 2029-02-19 | USPTO | ~6 months post US national phase |
| Response to USPTO OA deadline | 2029-05-19 | USPTO | 3 months from OA (extendable to 6) |
| | | | |
| **PHASE 5 ‚Äî Divisionals / CIPs (EU-first)** | | | |
| C3.1 LH‚ÇÇ EP divisional filing window opens | 2028-07-19 | **EPO** | After BWB-H‚ÇÇ design maturity; EP divisional |
| C3.2 Flight Energy EP divisional filing | 2028-10-19 | **EPO** | After simulation validation |
| C4.x EP independent / divisional filings | 2029-01-01 | **EPO** | As commercial interest develops |
| C3.1 US CIP (secondary, from EP divisional) | 2029-01-19 | USPTO (secondary) | Claim EP priority |
| | | | |
| **PHASE 6 ‚Äî Grant Targets** | | | |
| Unitary Patent grant (P0) | 2028-07-19 | **EU Unitary Patent Register (EPO)** | Single EU-wide right |
| EP validation grant (CH/NO) | 2028-09-19 | National EU-adjacent offices | |
| US patent grant target (P0) | 2030-06-19 | USPTO (secondary) | Subject to prosecution |
| UK patent grant target (P0) | 2030-08-19 | UKIPO (secondary) | Subject to prosecution |
| | | | |
| **PHASE 7 ‚Äî UPC Litigation Readiness** | | | |
| UPC registration of Unitary Patents | 2028-07-19 | **UPC Registry (Paris/Munich/Milan ‚Äî EU)** | Automatic for UP; UPC has exclusive jurisdiction |
| UPC opt-out NOT filed (AQUA-V policy) | N/A | | EU-wide enforcement preferred |

---

## Critical Deadlines ‚Äî Do Not Miss

| Deadline | Date | IP Registry | Consequence of Missing |
|---|---|---|---|
| P0 EP priority date | **2026-02-26** | **EPO** | Loss of EU priority anchor |
| PCT filing (12-month from EP priority) | **2027-02-19** | WIPO / EPO as ISA | Loss of PCT umbrella for secondary markets |
| EP grant ‚Üí Unitary Patent request (1 month) | **Within 1 month of grant** | **EPO** | Loss of Unitary Patent; must validate nationally |
| Non-EU national phase entry (30 months) | **2028-08-19** | Various | Loss of US/CA/JP rights |
| EPO prosecution reply | See OA date | EPO | Application deemed abandoned |

---

## Vertical Application Filing Windows

| Vertical | Filing Window | Registry | Trigger |
|---|---|---|---|
| Aerospace (C3.1, C3.2) | 2028‚Äì2029 | **EPO** (EP divisionals) | BWB-H‚ÇÇ TRL ‚â• 4; simulation data available |
| Supply Chain (C4.1) | 2028‚Äì2029 | **EPO** | QAOS supply chain pilot deployment |
| Predictive Maintenance (C4.2) | 2028‚Äì2030 | **EPO** | Fleet data validated |
| ESG Portfolio (C4.3) | 2029‚Äì2031 | **EPO** | EU taxonomy integration complete |

---

## EU IP Registry Summary

| Right | Registry | Location | EU Status |
|---|---|---|---|
| European Patent Application | EPO Patent Register | Munich, Germany | ‚úÖ EU institution |
| Unitary Patent | EPO Unitary Patent Register | Munich, Germany | ‚úÖ EU Regulation 1257/2012 |
| UPC proceedings | UPC Registry (Central Division) | Paris üá´üá∑ / Munich üá©üá™ / Milan üáÆüáπ | ‚úÖ EU court |
| EP validation (EPC states) | National IP offices in EU member states | Various EU cities | ‚úÖ EU |
| CH/NO/TR validation | Non-EU EPC state offices | Bern / Oslo / Ankara | ‚ö†Ô∏è Non-EU; EPC contracting states only |
| US national phase | USPTO | Alexandria, VA, USA | ‚ÑπÔ∏è Secondary; non-EU |

---

*All dates are targets. Statutory deadlines (PCT 12-month from priority, national phase 30-month) are hard limits.*  
*CCB must approve major phase transitions. EU framework mandate is non-waivable per GAIA-X data sovereignty principles.*
